Germline mutations in CDKN2A affecting the encoded p16INK4A protein (hereafter referred to as p16) are a major risk factor for familial melanoma, with a high proportion (40–60%) of families in which multiple individuals develop melanoma-carrying germline mutations in CDKN2A (1). The gene discussed is CDKN2A; the disease is melanoma.